Cycurion Secures $112M Backlog and Targets Higher-Margin ARx Platform Growth
Cycurion began 2026 with $2.2M in annual cost savings, net debt under $3M and over $5M in cash. The company reports a $112M contracted backlog and $1.35M in public health contract revenue while shifting to AI-driven ARx platform sales for higher-margin, sustainable profitability.
1. Operational Transformation and Financial Position
In 2025, Cycurion implemented $2.2 million in annualized cost savings, reduced net debt by over 70% to just under $3 million, and ended the year with more than $5 million in cash, laying the groundwork for disciplined spending and stronger liquidity.
2. Contracted Backlog and Revenue Visibility
As of April 2026, the company holds approximately $112 million in contracted backlog, providing multi-year revenue visibility, and anticipates public health contracts to contribute roughly $1.35 million in 2026 revenue, including about $1.165 million in new annual recurring revenue.
3. Path to Profitability and Margin Expansion
Cycurion is shifting toward higher-margin proprietary offerings by emphasizing its scalable AI-driven ARx platform and executing targeted acquisitions of products often delivering over 70% gross margins, alongside growing recurring managed services and strict cost discipline.
4. Valuation Gap and Shareholder Protections
Trading at roughly 0.5x trailing revenue versus peers at 5–12x, management expects backlog conversion and margin growth to narrow this valuation disconnect, while pursuing a John Doe lawsuit and litigation hold letters to safeguard shareholders against market manipulation.